Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025
Webcast and Conference Call To be Held Tuesday, November 25, 2025, 8:30 am ETNEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE)...
News
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025
Three BriaCell poster presentations include updated key biomarker data from BriaCell’s pivotal Phase 3 study and updated survival data from...
HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease
First Patient Dosed at The Ohio State University Wexner Medical Center in this Multi-Center Trial Active component of HCW9302 is...
Aurora Spine Corporation Announces Record Third Quarter Financial Results
- Company to host conference call Today, November 18th at 11am ET/8am PT –NOT FOR DISTRIBUTION IN THE UNITED STATES OR...
24/7 Market News- Kraig Biocraft Laboratories Receives Spider Silk Order from Global Performance Sports Brand, Marking Several Major Milestones
Move a Key Commercialization CatalystDENVER, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories (OTCQB: KBLB) (“Kraig Labs” or “the...
HelixAI launches a new agentic operating system to bring the power of autonomous AI to life sciences
PRESS RELEASE New operating system enables scientists to move from copilot to autopilot, unifying diverse in silico, wet lab research...
EDAP to Present at Piper Sandler 37th Annual Healthcare Conference
EDAP to Present at Piper Sandler 37th Annual Healthcare Conference Company to Present and Host 1x1 Investor Meetings on Tuesday,...
Harrow Announces Closing of Acquisition of Melt Pharmaceuticals
NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in...
Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer Patient Treated with Namodenoson
Pivotal Phase III liver cancer study enrolling in Europe and Israel RAMAT GAN, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) --...
Aiomics Supports Independent Research at Charité to Advance Evidence-Based Clinical Documentation
Project discussion at Charité The founder of aiomics speaking about the implementation assessment with Professor Akira Sebastian-Poncette and MD student...
MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor
LA JOLLA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
Rakovina Therapeutics’ President & CSO to Present and Join Expert Panel at the 9th Annual DDR Inhibitors Summit
VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a...
A natural breakthrough in protecting cereals and field crops
Syngenta and Amoeba SA to develop and commercialize biocontrol solutions for EU and UKChassieu, France Basel, Switzerland , Nov. 18,...
Uma inovação natural na proteção de cereais e culturas agrícolas
Syngenta e Amoéba SA vão desenvolver e comercializar soluções de biocontrolo na UE e no Reino UnidoBasileia, Suíça Chassieu, França,...
HelixAI launches a new agentic operating system to bring the power of autonomous AI to life sciences
PRESS RELEASE New operating system enables scientists to move from copilot to autopilot, unifying diverse in silico, wet lab research...
Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer
VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of...
Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets
Strategy will combine internal innovation, licensing, and strategic acquisitions to drive sustainable value creation for shareholdersStrategic initiative follows positive topline...
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s giredestrant becomes the first oral SERD to show superior invasive disease-free survival in early breast cancer
At interim analysis, giredestrant demonstrated a statistically significant and clinically meaningful benefit versus standard-of-care endocrine monotherapyThese unprecedented results support its...
Apollomics Announces Changes to its Board of Directors and Composition of Committees
FOSTER CITY, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California-based late-stage...
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
NEW HAVEN, Conn., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced the pricing of an...